Large-cap Health Care company Henry Schein has logged a 0.9% change today on a trading volume of 17,961. The average volume for the stock is 1,132,037.
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. Based in Melville, United States the company has 24,000 full time employees and a market cap of $9,823,478,784.
The company is now trading -1.27% away from its average analyst target price of $75.36 per share. The 11 analysts following the stock have set target prices ranging from $65.0 to $82.0, and on average give Henry Schein a rating of hold.
Over the last 12 months HSIC shares have declined by -17.0%, which represents a difference of -38.5% when compared to the S&P 500. The stock's 52 week high is $89.6 per share and its 52 week low is $60.01. With its net margins declining an average -2.2% over the last 6 years, Henry Schein declining profitability gives us reason to believe its stock price will continue to underwhelm.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | 12,693,000 | 445,000 | 4 | 0.0 |
| 2022 | 12,647,000 | 538,000 | 4 | -20.0 |
| 2021 | 12,401,000 | 631,000 | 5 | 25.0 |
| 2020 | 10,119,000 | 404,000 | 4 | -42.86 |
| 2019 | 9,985,803 | 694,734 | 7 | 75.0 |
| 2018 | 13,201,995 | 535,881 | 4 |
